Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
Alphamab Co Ltd

Alphamab Co Ltd (9966 HK)

117
Analysis
Health CareChina
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
30 Jun 2025 00:55

Pre-IPO China Medical System (867 HK) - About the IPO in Singapore and Concerns on Valuation Outlook

Listing in SGX opens a new chapter and CMS is undergoing pipeline adjustments and strategic transformation. But as valuation logic changes, license...

Logo
314 Views
Share
29 Jun 2025 01:19

China Healthcare Weekly (Jun.29) - Biotech Valuation Bubble Is About to Burst, Innovent's Placement

The valuation bubble of innovative drug companies may burst soon, with some founders/shareholders already cashing out. Innovent's Placing Price of...

Logo
293 Views
Share
26 Jun 2025 00:55

Pre-IPO Nanjing Leads Biolabs (PHIP Updates) - Thoughts on the Valuation and the Outlook

LBL-024 won't boost performance due to small market,while LBL-007 face uncertain outlook.CD3 pipeline offer hope,but early investors' quit indicate...

Logo
254 Views
Share
07 May 2025 00:55

Pre-IPO Xuanzhu Biopharmaceutical- Outdated Pipelines Are Difficult to Bring Good Investment Returns

​Sihuan's acquisition of Combio aims to create a strong innovative drug business Xuanzhu, but concerns arise over its outdated pipeline,...

Logo
247 Views
Share
25 Mar 2025 00:55

Pre-IPO Duality Biotherapeutics (PHIP Updates) - Some Points Worth the Attention

​DB-1303 face challenges in commercialization.The priority for DB-1311 is to verify the druggability. Duality’s pre-IPO valuation isn't...

Logo
407 Views
Share
x